News

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine ...
Proof-of-concept shows mRNA genetic circuitry able to target expression of IL-12 to tumors when systemically delivered ...
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Investing in the specialist workforce and overcoming access barriers is essential to successful delivery of this therapy in the NHS, write Jessie Enakhumhe and Yasmin Sheikh Casgevy, or exagamglogene ...
A breakthrough CRISPR therapy, VERVE-102, shows promise for lifelong cholesterol control with a single dose, achieving up to ...
Dr. Soliman Abdel Kader Fakeeh Hospital Co. (Fakeeh Care) and its subsidiaries signed a strategic memorandum of understanding ...
SEATTLE, April 28, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of multiple abstracts, including two oral presentations, at the ...
Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene ...
An autopsy report confirms the main cause of actor Gene Hackman's death was heart disease and notes he was in the advanced stages of Alzheimer’s disease and likely had not ...
Dr. Natalia Misciattelli, Chief Executive Officer of AAVantgarde said, “We are thrilled to welcome Rasmus Holm-Jorgensen as our new CFO. His deep experience in strategy, finance, and global operations ...
A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...
Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level.